Contrarius Investment Management LTD Myriad Genetics Inc Transaction History

Contrarius Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$27.75 - $40.17 $6.88 Million - $9.97 Million	-248,090 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$28.83 - $41.01 $356,194 - $506,678	12,355 Added 5.24%	248,090 $7.33 Million
Q4 2017 Feb 09, 2018	SELL	$28.45 - $37.14 $2.06 Million - $2.69 Million	-72,328 Reduced 23.48%	235,735 $8.1 Million
Q3 2017 Nov 08, 2017	BUY	$24.01 - $36.2 $7.4 Million - $11.2 Million	308,063	308,063 $11.1 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Contrarius Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Contrarius Investment Management LTD with notifications on news.